Diagnostic evaluation demonstrates rapid screening and quantification of urinary pathogens using CeO2−x/Au nanospheres, indicating high diagnostic accuracy in clinical urine samples.
The integration of rapid on‐site screening with precise quantification is critically important for the diagnosis of urinary tract infections (UTIs). However, current detection methods often struggle to balance between screening efficiency and quantitative accuracy. Herein, we first report a colorimetric‐terahertz (THz) dual‐mode sensing platform powered by CeO 2−x /Au nanospheres for pathogenic bacteria in UTIs. The engineered CeO 2−x /Au nanospheres exhibit outstanding peroxidase‐like activity and dielectric response under the strong localized field enhancement of THz metamaterial, establishing a sequential activation dual‐signal output mechanism. Rapid preliminary screening of pathogens is realized via smartphone image recognition by utilizing CeO 2−x /Au nanospheres unbound from bacterial surfaces to catalyze colorimetric reactions. Subsequently, the bacteria‐conjugated nanospheres trigger significant changes in the local dielectric environment, leading to distinct frequency shifts that enable precise quantification in THz mode, with limit of detection (LOD) values for common UTI pathogens ranging from 4.58 to 9.31 × 10 2 CFU/mL. This strategy enables rapid positive/negative discrimination and accurate quantification of bacterial loads in positive samples, achieving outstanding classification (AUC = 0.993) for 75 clinical urine samples. Enabled by CeO 2−x /Au composite nanospheres, the dual‐mode platform with affordability (∼$6.8) and time‐efficiency (<1 h) demonstrates potential for UTI diagnosis across diverse scenarios through a tiered approach.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: